Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Olesja Parmová"'
Publikováno v:
Neurologie pro praxi. 21:3-9
Pompeho nemoc (glykogenoza II. typu) je vzacne autosomalně recesivni dědicne metabolicke onemocněni. Průběh onemocněni a celkovou dobu přežiti lze ovlivnit enzymovou substitucni terapii. Neuromuskularni centrum 2. LF UK a FN Motol a Neuromusk
Publikováno v:
Muscle & Nerve. 59:431-435
Introduction The objective of this study was to develop a simple method for quantitative assessment of myotonia in patients with myotonic dystrophy type 1 (DM1) and DM2, to compare the myotonia severity, and to correlate this objective outcome with a
Autor:
Radim Mazanec, Eva Kralickova, Josef Bednarik, Olesja Parmová, Martina Podborská, Petra Strádalová, Monika Hulová, Ladislav Dušek, Iva Šrotová, Jiri Jarkovsky, Lívie Mensová, Igor Crha, Eva Vlčková, Lenka Jurikova, S. Vohanka
Publikováno v:
Medicine
Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-Müllerian hormone) is currently considered the best measure of ovarian reser
Autor:
Stanislav Voháňka, Olesja Parmová
Publikováno v:
Neurologie pro praxi. 17:240-243
Myotonicka dystrofie je nejcastějsi formou svalove dystrofie u dospělých. Hlavnimi projevy jsou progredujici svalova slabost, myotonie a charakteristicka multiorganova postiženi. Bolest je castým (až 75 % pacientů) a zavažným přiznakem chor
Autor:
Daniela Vlazna, Peter Krkoska, Michaela Sladeckova, Olesja Parmova, Tamara Barusova, Karolina Hrabcova, Stanislav Vohanka, Katerina Matulova, Blanka Adamova
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
IntroductionMyotonic dystrophy type 2 (MD2) presents with a varied manifestation. Even though the myopathy in these patients is more widespread, axial musculature involvement is one of the most prominent conditions. MD2 patients also often report chr
Externí odkaz:
https://doaj.org/article/d2d07ecac85f41029f17256d0354b843
Autor:
Lenka Fajkusová, J. Junkerova, E. Ehler, Olesja Parmová, J. Stanek, R. Mazanec, M. Forgac, S. Vohanka, Jana Strenková, Jana Haberlová, P. Ridzon
Publikováno v:
Neuromuscular Disorders. 27:S129-S130
Publikováno v:
International Journal of Neurology and Neurotherapy. 1
Background: Myotonic dystrophy is the most common form of muscular dystrophy in adults. Pain is reported in various hereditary muscular diseases at a frequency of 64%–83%. Methods: A group of 70 patients with myotonic dystrophy (21 persons with typ
Autor:
Radim Mazanec, Jana Strenková, Olesja Parmová, T. Bozovsky, A. Vávra, J. Junkerova, E. Ehler, P. Ridzon, P. Kunc, M. Forgac, S. Vohanka
Publikováno v:
Journal of the Neurological Sciences. 357:e347-e348
Publikováno v:
Neuromuscular Disorders. 24:891-892
Myotonic dystrophy (DM) is a multisystem disorder characterized by skeletal muscle and multiple organ impairment. The aim of the study is to compare our local data from the registry with that known in other countries. The data from the local part of
Publikováno v:
Neuromuscular Disorders. 23:834-835
Myotonic dystrophy is a dominantly inherited disorder with multisystem clinical features. In Czech Republic (Central Europe), the type 2 (MD2) is more frequent than type 1 (MD1). Both types share some clinical features, but also have substantial diff